Mednax is a medical care facilities business based in the US. Mednax shares (MD) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $14.76 – a decrease of 6.35% over the previous week. Mednax employs 5,450 staff and has a trailing 12-month revenue of around $2 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $14.76 |
|---|---|
| 52-week range | $6.62 - $16.41 |
| 50-day moving average | $12.46 |
| 200-day moving average | $9.65 |
| Wall St. target price | $15.92 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-2.27 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $15.22 from 2024-11-13
| 1 week (2024-11-08) | -3.43% |
|---|---|
| 1 month (2024-10-15) | 23.84% |
| 3 months (2024-08-15) | 47.77% |
| 6 months (2024-05-15) | 85.61% |
| 1 year (2023-11-15) | 55.31% |
|---|---|
| 2 years (2022-11-15) | -5.58% |
| 3 years (2021-11-15) | 28 |
| 5 years (2019-11-15) | 26.69 |
Valuing Mednax stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mednax's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mednax's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.88. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Mednax's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Mednax's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $199 million.
The EBITDA is a measure of a Mednax's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2 billion |
|---|---|
| Operating margin TTM | 10.26% |
| Gross profit TTM | $467 million |
| Return on assets TTM | 4.67% |
| Return on equity TTM | -29.86% |
| Profit margin | -12.65% |
| Book value | $8.67 |
| Market Capitalization | $1.3 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Mednax.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 19.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Mednax's overall score of 19.73 (as at 12/31/2018) is pretty good – landing it in it in the 22nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Mednax is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.84/100
Mednax's environmental score of 1.84 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Mednax is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 8.57/100
Mednax's social score of 8.57 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Mednax is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 5.5/100
Mednax's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Mednax is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Mednax scored a 1 out of 5 for controversy – the highest score possible, reflecting that Mednax has managed to keep its nose clean.
Mednax Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 19.73 |
|---|---|
| Total ESG percentile | 21.62 |
| Environmental score | 1.84 |
| Environmental score percentile | 1 |
| Social score | 8.57 |
| Social score percentile | 1 |
| Governance score | 5.5 |
| Governance score percentile | 1 |
| Level of controversy | 1 |
We're not expecting Mednax to pay a dividend over the next 12 months.
Mednax's shares were split on a 2:1 basis on 19 December 2013 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Mednax shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Mednax shares which in turn could have impacted Mednax's share price.
Over the last 12 months, Mednax's shares have ranged in value from as little as $6.62 up to $16.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Mednax's is 1.555. This would suggest that Mednax's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Pediatrix Medical Group, Inc. , together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.